Enanta Pharmaceuticals to Present Data for its STAT6 Inhibitor Program at IMMUNOLOGY2026TM, the Annual Meeting of the American Association of Immunologists (AAI)
Go back to Enanta Pharmaceuticals to Present Data for its STAT6 Inhibitor Program at IMMUNOLOGY2026TM, the Annual Meeting of the American Association of Immunologists (AAI)| ENANTA PHARM (NASDAQ: ENTA) | Delayed: 13.37 +0.71 (5.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.66 | 52 Week High | $34.49 | |||
| Open | $12.85 | 52 Week Low | $20.39 | |||
| Day High | $13.40 | P/E | N/A | |||
| Day Low | $12.65 | EPS | $-3.18 | |||
| Volume | 225,467 | |||||
